These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 18721185)

  • 1. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
    Quentin W; König HH; Schmidt JO; Kalk A
    Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006.
    Krentz HB; Gill MJ
    HIV Med; 2008 Oct; 9(9):721-30. PubMed ID: 18643856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico.
    Aracena-Genao B; Navarro JO; Lamadrid-Figueroa H; Forsythe S; Trejo-Valdivia B
    AIDS; 2008 Jul; 22 Suppl 1():S141-8. PubMed ID: 18664946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing efficiency and costs of scaling up HIV treatment.
    Cleary SM; McIntyre D; Boulle AM
    AIDS; 2008 Jul; 22 Suppl 1():S35-42. PubMed ID: 18664951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. User fees and access to ARV treatment for persons living with HIV/AIDS: implementation and challenges in Burkina Faso, a limited-resource country.
    Kouanda S; Bocoum FY; Doulougou B; Bila B; Yameogo M; Sanou MJ; Sawadogo M; Sondo B; Msellati P; Desclaux A
    AIDS Care; 2010 Sep; 22(9):1146-52. PubMed ID: 20824567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.
    Souteyrand YP; Collard V; Moatti JP; Grubb I; Guerma T
    AIDS; 2008 Jul; 22 Suppl 1():S161-8. PubMed ID: 18664948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough?
    Moon S; Van Leemput L; Durier N; Jambert E; Dahmane A; Jie Y; Wu G; Philips M; Hu Y; Saranchuk P
    AIDS Care; 2008 Sep; 20(8):984-94. PubMed ID: 18777223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to antiretroviral treatment in developing countries: Which financing strategies are possible?
    Beaulière A; Le Maux A; Trehin C; Perez F
    Rev Epidemiol Sante Publique; 2010 Jun; 58(3):171-9. PubMed ID: 20430553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroeconomic and household-level impacts of HIV/AIDS in Botswana.
    Jefferis K; Kinghorn A; Siphambe H; Thurlow J
    AIDS; 2008 Jul; 22 Suppl 1():S113-9. PubMed ID: 18664942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and efficiency of HIV voluntary counselling and testing centres in Andhra Pradesh, India.
    Dandona L; Sisodia P; Ramesh YK; Kumar SG; Kumar AA; Rao MC; Someshwar M; Hansl B; Marshall N; Marseille E; Kahn JG
    Natl Med J India; 2005; 18(1):26-31. PubMed ID: 15835489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining catastrophic costs and benefit incidence of subsidized antiretroviral treatment (ART) programme in south-east Nigeria.
    Onwujekwe O; Dike N; Chukwuka C; Uzochukwu B; Onyedum C; Onoka C; Ichoku H
    Health Policy; 2009 May; 90(2-3):223-9. PubMed ID: 19036466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
    Tagar E; Sundaram M; Condliffe K; Matatiyo B; Chimbwandira F; Chilima B; Mwanamanga R; Moyo C; Chitah BM; Nyemazi JP; Assefa Y; Pillay Y; Mayer S; Shear L; Dain M; Hurley R; Kumar R; McCarthy T; Batra P; Gwinnell D; Diamond S; Over M
    PLoS One; 2014; 9(11):e108304. PubMed ID: 25389777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to access to antiretroviral treatment in developing countries: a review.
    Posse M; Meheus F; van Asten H; van der Ven A; Baltussen R
    Trop Med Int Health; 2008 Jul; 13(7):904-13. PubMed ID: 18466183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the variation in costs among HIV primary care providers.
    Gilman BH; Green JC
    AIDS Care; 2008 Oct; 20(9):1050-6. PubMed ID: 18825514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial burden of health care for HIV/AIDS patients in Vietnam.
    Tran BX; Duong AT; Nguyen LT; Hwang J; Nguyen BT; Nguyen QT; Nong VM; Vu PX; Ohinmaa A
    Trop Med Int Health; 2013 Feb; 18(2):212-8. PubMed ID: 23210600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M; Vella S
    Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The obligation to provide antiretroviral treatment in HIV prevention trials.
    Lo B; Padian N; Barnes M
    AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.